Zhiyong Wang

Title: Zhiyong Wang: Innovator in Diabetes Research

Introduction

Zhiyong Wang is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of diabetes research. His innovative work has led to the development of a unique animal model that aids in understanding various physiological phenomena related to diabetes.

Latest Patents

Zhiyong Wang holds a patent for a "PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes." This patent discloses a null mutant rodent that comprises an artificially induced PTTG null mutation in its germ cells. The rodent can be generated through homologous recombination in embryonic stem cells or germ cells. This inventive model allows researchers to study mammalian physiology at multiple levels, focusing on various phenotypes such as hyperglycemia, hypoinsulinaemia, and diabetes. The patent also includes disclosures for somatic or germ cells obtained from the null mutant rodent and a cell line derived from these cells.

Career Highlights

Zhiyong Wang is affiliated with Cedars-Sinai Medical Center, where he continues to advance research in diabetes and related physiological conditions. His work has garnered attention for its potential to provide insights into complex health issues.

Collaborations

Zhiyong Wang collaborates with Shlomo Melmed, enhancing the research efforts at Cedars-Sinai Medical Center. Their combined expertise contributes to the advancement of medical knowledge in their respective fields.

Conclusion

Zhiyong Wang's innovative research and patent contributions significantly impact the understanding of diabetes and related physiological phenomena. His work exemplifies the importance of scientific innovation in addressing complex health challenges.